Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Several new anti-integrin agents are currently being investigated in clinical trials.
Investigational drugs include: Etrolizumab, Abrilumab, Ontamalimab, Carotegrast methyl, PTG-100
Most new anti-integrins appear to improve outcomes in UC but not in CD. However, these data are not yet definitive, and several pivotal trials are still underway. The ongoing research will provide more clarity on the efficacy and safety of these ag…